Recently, the PSMD14 inhibitor capzimin (CZM), a derivative of quinoline-8-thiol, stabilized a subset of proteasome substrates in treated cells and inhibited the proliferation of cancer cells [12,13]. The gene discussed is PSMD14; the disease is cancer.